Rhematoid Arthritis
·MeSH: Arthritis
Prevalence
239.6 / 100K
Incidence
13.3 / 100K/yr
1 drug in development·1 company·2 clinical trials
Drug Pipeline by Phase
Phase 2(1)
| Drug | Company |
|---|---|
| jade201 | Jade Biosciences, Inc. (JBIO) |
Frequently asked questions
How many drugs are in development for Rhematoid Arthritis?
BioSniper tracks 1 drug in development for Rhematoid Arthritis across 1 company.
How many clinical trials target Rhematoid Arthritis?
There are 2 clinical trials targeting Rhematoid Arthritis tracked by BioSniper.
What is the prevalence of Rhematoid Arthritis?
The estimated prevalence of Rhematoid Arthritis is approximately 239.6 per 100,000 population.
Deep-dive into Rhematoid Arthritis
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis